Breaking NewsTaylor Mammon CBD Bought By US Leader Following Three-Year...

Taylor Mammon CBD Bought By US Leader Following Three-Year Courtship

-

LEADING UK CBD firm Taylor Mammon has been bought by premier US operator GenCanna to create one of the world’s major sector players.

Formed in 2018 Taylor Mammon’s co-founder and Managing Director Nathan Wogman says the deal positions it for ‘significant international growth’.

The move culminates ta three-year partnership during which GenCanna has served as Taylor Mammon’s primary source of CBD and other cannabinoids for infusion into brand products.

Taylor Mammon is a white label manufacturer and brand distributor of CBD-infused goods. GenCanna, is a leading producer of hemp-derived, THC-free, premium CBD and other cannabinoids. 

GenCanna CEO Andrew Barnett said: “As one of our long-term and valued customers, we admired Taylor Mammon’s philosophy and approach to CBD.

“This alliance — which we understand is the first of its kind for a UK-based CBD company — drives unique and mutually beneficial operational and marketing synergies that will catapult product development, sales, and revenue opportunities within our respective geographies.” 

The acquisition follows 18-months work by Taylor Mammon to prepare its Novel Foods Application in tandem with GenCanna. 


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Plans Unveiled For First National Health Service-Backed Medical Cannabis Clinical Trial

AFTER launching a patient registry earlier this year further signs the UK’s National Health Service is warming to cannabis...

Reakiro – Europe’s Leading CBD And Hemp Brand – Delivers The Complete B2B & B2C Package

IN a time when CBD products are becoming unavoidable in the health, wellness and fitness industries, it is more...

Is Luxembourg’s Quest To Introduce An Adult-Use Cannabis Programme Going Up In Smoke?

CONCERNS over Luxembourg’s intent to become the first European country to legalise adult-use cannabis have emerged. In an interview on...

Cannabis Is Now A Compelling Opportunity For The Main Tobacco Companies

International cannabis expert, Barbara Pastori, of Prohibition Partners shares her thoughts on why cannabis is a compelling opportunity for...

Oxford Cannabinoid Technologies Holdings Sign Exclusive Worldwide License Agreement With Canopy Growth

Oxford Cannabinoid Technologies Holdings plc (OCTP), the holding company of Oxford Cannabinoid Technologies Ltd (“OCT”) (together, the “Group”), a...

With Global Cannabis Cultivation Capacity Set To Outstrip Demand One Hundredfold – What Happened To The ‘Green’ Rush?

CANNABIS investors need to be wary when it comes to cultivation, says Oliver Zugel, Founder and CEO FoliuMed Holdings. Where...

Must read

Plans Unveiled For First National Health Service-Backed Medical Cannabis Clinical Trial

AFTER launching a patient registry earlier this year further...

Is Luxembourg’s Quest To Introduce An Adult-Use Cannabis Programme Going Up In Smoke?

CONCERNS over Luxembourg’s intent to become the first European...

You might also likeRELATED
Recommended to you